Latest News by Industry
BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $300.6 million in its second quarter.
The Bridgewater, New Jersey-based company said it had a loss of $1.94 per share.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.22 per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $90.3 million in the period, beating Street forecasts. Six analysts surveyed by Zacks expected $88 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM